Multispectral imaging combined with structured illumination for contactless diagnosis and differentiation of dysplasia in the cervix and vulva

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039197

Enrollment

100

Registered

2026-02-03

Start date

2025-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Detection of precancerous lesions and malignant changes in the cervix and vulva

Interventions

Group 1: Included are female patients =18 years of age at the University Women's Hospital in Tübingen with clinically suspected dysplasia in the cervical or vulvar area who attend the dysplasia clinic

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age = 18 years - Written consent after receiving information - Clinical suspicion of dysplasia in the cervix or vulva - Attendance at a dysplasia consultation or undergoing surgery

Exclusion criteria

Exclusion criteria: - Existing pregnancy - Expected lack of compliance by the patient or inability of the patient to understand the meaning and purpose of the clinical trial - Lack of patient consent

Design outcomes

Primary

Measure	Time frame
Identification of relevant MSI parameters with particularly high sensitivity for the detection of dysplasia.	—

Secondary

Measure	Time frame
Comparison of the MSI system combined with structured illumination with data from other systems (MSI, HSI) without structured illumination.	—

Countries

Germany

Contacts

Public ContactMartin Weiß

Department für Frauengesundheit am Universitätsklinikum Tübingen

martin.weiss@med.uni-tuebingen.de+497071 2982211

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026